Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to an AVP booster dose in previously vaccinated adults
ISRCTN10278402Phase 4Completed
- Sponsor
- Defence Science and Technology Laboratory
- Start
- May 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label trial of anthrax vaccine adsorbed in anthrax (2 arms), sponsored by Defence Science and Technology Laboratory. Primary endpoint: Immune response after AVP booster. Started May 2009; status: completed.
02
Drugs
anthrax vaccine adsorbed
03
Conditions
anthrax
Beyond the preview
Go deeper on ISRCTN10278402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10278402.